A carregar...
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV
Darunavir (DRV) is a high affinity (4.5×10(-12) M, ΔG = -15.2 kcal/mol) HIV-1 protease inhibitor. Two drug-resistant protease variants FLAP+ (L10I, G48V, I54V, V82A) and ACT (V82T, I84V) decrease the binding affinity with DRV by 1.0 kcal/mol and 1.6 kcal/mol respectively. In this study the absolute...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2882104/ https://ncbi.nlm.nih.gov/pubmed/20543885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ct9004678 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|